nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyridostigmine—BCHE—peripheral nervous system neoplasm	0.714	1	CbGaD
Pyridostigmine—BCHE—Cisplatin—peripheral nervous system neoplasm	0.0778	0.465	CbGbCtD
Pyridostigmine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0297	0.178	CbGbCtD
Pyridostigmine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0276	0.165	CbGbCtD
Pyridostigmine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0127	0.0758	CbGbCtD
Pyridostigmine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0116	0.0695	CbGbCtD
Pyridostigmine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00793	0.0474	CbGbCtD
Pyridostigmine—Neostigmine—BCHE—peripheral nervous system neoplasm	0.00273	0.418	CrCbGaD
Pyridostigmine—Rivastigmine—BCHE—peripheral nervous system neoplasm	0.00273	0.418	CrCbGaD
Pyridostigmine—Neostigmine—ABCB1—peripheral nervous system neoplasm	0.00107	0.164	CrCbGaD
Pyridostigmine—Myalgia—Isotretinoin—peripheral nervous system neoplasm	0.000369	0.0033	CcSEcCtD
Pyridostigmine—Myalgia—Melphalan—peripheral nervous system neoplasm	0.000364	0.00326	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Vincristine—peripheral nervous system neoplasm	0.000362	0.00324	CcSEcCtD
Pyridostigmine—Alopecia—Dactinomycin—peripheral nervous system neoplasm	0.000359	0.00322	CcSEcCtD
Pyridostigmine—Sweating increased—Etoposide—peripheral nervous system neoplasm	0.000358	0.00321	CcSEcCtD
Pyridostigmine—Lacrimation increased—Epirubicin—peripheral nervous system neoplasm	0.000357	0.00319	CcSEcCtD
Pyridostigmine—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.000356	0.00319	CcSEcCtD
Pyridostigmine—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.000356	0.00319	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.000344	0.00309	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.000342	0.00306	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.000342	0.00306	CcSEcCtD
Pyridostigmine—Alopecia—Alitretinoin—peripheral nervous system neoplasm	0.000333	0.00298	CcSEcCtD
Pyridostigmine—Neck pain—Epirubicin—peripheral nervous system neoplasm	0.000333	0.00298	CcSEcCtD
Pyridostigmine—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.00033	0.00296	CcSEcCtD
Pyridostigmine—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.00033	0.00296	CcSEcCtD
Pyridostigmine—Lacrimation increased—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.00295	CcSEcCtD
Pyridostigmine—Bradycardia—Cisplatin—peripheral nervous system neoplasm	0.000327	0.00293	CcSEcCtD
Pyridostigmine—Hypotension—Melphalan—peripheral nervous system neoplasm	0.000326	0.00292	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.000325	0.00291	CcSEcCtD
Pyridostigmine—Flatulence—Alitretinoin—peripheral nervous system neoplasm	0.000323	0.0029	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.000322	0.00288	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.000322	0.00288	CcSEcCtD
Pyridostigmine—Alopecia—Vincristine—peripheral nervous system neoplasm	0.000321	0.00288	CcSEcCtD
Pyridostigmine—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.00032	0.00287	CcSEcCtD
Pyridostigmine—Salivary hypersecretion—Epirubicin—peripheral nervous system neoplasm	0.000319	0.00286	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.000318	0.00285	CcSEcCtD
Pyridostigmine—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.000317	0.00284	CcSEcCtD
Pyridostigmine—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.000317	0.00284	CcSEcCtD
Pyridostigmine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.000314	0.00281	CcSEcCtD
Pyridostigmine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.000314	0.00281	CcSEcCtD
Pyridostigmine—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.000313	0.00281	CcSEcCtD
Pyridostigmine—Neck pain—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.00276	CcSEcCtD
Pyridostigmine—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.000302	0.0027	CcSEcCtD
Pyridostigmine—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.000301	0.0027	CcSEcCtD
Pyridostigmine—Salivary hypersecretion—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.00264	CcSEcCtD
Pyridostigmine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000294	0.00263	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Etoposide—peripheral nervous system neoplasm	0.000293	0.00262	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Epirubicin—peripheral nervous system neoplasm	0.000292	0.00262	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000291	0.00261	CcSEcCtD
Pyridostigmine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000291	0.00261	CcSEcCtD
Pyridostigmine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000291	0.00261	CcSEcCtD
Pyridostigmine—Agitation—Vincristine—peripheral nervous system neoplasm	0.000291	0.0026	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000289	0.00259	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000289	0.00259	CcSEcCtD
Pyridostigmine—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.000288	0.00258	CcSEcCtD
Pyridostigmine—Hypertonia—Epirubicin—peripheral nervous system neoplasm	0.000288	0.00258	CcSEcCtD
Pyridostigmine—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000284	0.00255	CcSEcCtD
Pyridostigmine—Vertigo—Vincristine—peripheral nervous system neoplasm	0.000284	0.00255	CcSEcCtD
Pyridostigmine—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.000284	0.00254	CcSEcCtD
Pyridostigmine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000283	0.00254	CcSEcCtD
Pyridostigmine—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000282	0.00252	CcSEcCtD
Pyridostigmine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000281	0.00252	CcSEcCtD
Pyridostigmine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000281	0.00252	CcSEcCtD
Pyridostigmine—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.000279	0.0025	CcSEcCtD
Pyridostigmine—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000279	0.0025	CcSEcCtD
Pyridostigmine—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000279	0.0025	CcSEcCtD
Pyridostigmine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000277	0.00248	CcSEcCtD
Pyridostigmine—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.000276	0.00247	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Epirubicin—peripheral nervous system neoplasm	0.000276	0.00247	CcSEcCtD
Pyridostigmine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000274	0.00245	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.00242	CcSEcCtD
Pyridostigmine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00027	0.00242	CcSEcCtD
Pyridostigmine—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000269	0.00241	CcSEcCtD
Pyridostigmine—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000269	0.00241	CcSEcCtD
Pyridostigmine—Hypertonia—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.00239	CcSEcCtD
Pyridostigmine—Eye pain—Epirubicin—peripheral nervous system neoplasm	0.000264	0.00237	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000263	0.00236	CcSEcCtD
Pyridostigmine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000263	0.00235	CcSEcCtD
Pyridostigmine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00026	0.00233	CcSEcCtD
Pyridostigmine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00026	0.00233	CcSEcCtD
Pyridostigmine—Alopecia—Etoposide—peripheral nervous system neoplasm	0.00026	0.00233	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000259	0.00232	CcSEcCtD
Pyridostigmine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000257	0.0023	CcSEcCtD
Pyridostigmine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000256	0.00229	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.00228	CcSEcCtD
Pyridostigmine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000254	0.00227	CcSEcCtD
Pyridostigmine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000254	0.00227	CcSEcCtD
Pyridostigmine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00025	0.00224	CcSEcCtD
Pyridostigmine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00025	0.00224	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00025	0.00224	CcSEcCtD
Pyridostigmine—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000246	0.00221	CcSEcCtD
Pyridostigmine—Eye pain—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.00219	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000244	0.00219	CcSEcCtD
Pyridostigmine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000244	0.00218	CcSEcCtD
Pyridostigmine—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.000243	0.00218	CcSEcCtD
Pyridostigmine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000242	0.00217	CcSEcCtD
Pyridostigmine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000242	0.00217	CcSEcCtD
Pyridostigmine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000242	0.00217	CcSEcCtD
Pyridostigmine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000241	0.00216	CcSEcCtD
Pyridostigmine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000241	0.00215	CcSEcCtD
Pyridostigmine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000239	0.00214	CcSEcCtD
Pyridostigmine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000238	0.00213	CcSEcCtD
Pyridostigmine—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000238	0.00213	CcSEcCtD
Pyridostigmine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000238	0.00213	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000236	0.00212	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000235	0.00211	CcSEcCtD
Pyridostigmine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000232	0.00208	CcSEcCtD
Pyridostigmine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00023	0.00206	CcSEcCtD
Pyridostigmine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000228	0.00205	CcSEcCtD
Pyridostigmine—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000227	0.00203	CcSEcCtD
Pyridostigmine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000227	0.00203	CcSEcCtD
Pyridostigmine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000225	0.00202	CcSEcCtD
Pyridostigmine—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.00202	CcSEcCtD
Pyridostigmine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000225	0.00201	CcSEcCtD
Pyridostigmine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000225	0.00201	CcSEcCtD
Pyridostigmine—Rash—Topotecan—peripheral nervous system neoplasm	0.000225	0.00201	CcSEcCtD
Pyridostigmine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000224	0.00201	CcSEcCtD
Pyridostigmine—Headache—Topotecan—peripheral nervous system neoplasm	0.000223	0.002	CcSEcCtD
Pyridostigmine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000223	0.002	CcSEcCtD
Pyridostigmine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000223	0.002	CcSEcCtD
Pyridostigmine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000223	0.00199	CcSEcCtD
Pyridostigmine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000223	0.00199	CcSEcCtD
Pyridostigmine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000222	0.00199	CcSEcCtD
Pyridostigmine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000222	0.00199	CcSEcCtD
Pyridostigmine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000221	0.00198	CcSEcCtD
Pyridostigmine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000221	0.00198	CcSEcCtD
Pyridostigmine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000221	0.00198	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000221	0.00198	CcSEcCtD
Pyridostigmine—Rash—Melphalan—peripheral nervous system neoplasm	0.00022	0.00197	CcSEcCtD
Pyridostigmine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00022	0.00197	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000219	0.00196	CcSEcCtD
Pyridostigmine—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000219	0.00196	CcSEcCtD
Pyridostigmine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000213	0.00191	CcSEcCtD
Pyridostigmine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000213	0.00191	CcSEcCtD
Pyridostigmine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000213	0.00191	CcSEcCtD
Pyridostigmine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000212	0.0019	CcSEcCtD
Pyridostigmine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000212	0.0019	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000211	0.00189	CcSEcCtD
Pyridostigmine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000211	0.00189	CcSEcCtD
Pyridostigmine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00021	0.00188	CcSEcCtD
Pyridostigmine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00021	0.00188	CcSEcCtD
Pyridostigmine—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.00188	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000208	0.00186	CcSEcCtD
Pyridostigmine—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000208	0.00186	CcSEcCtD
Pyridostigmine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000207	0.00186	CcSEcCtD
Pyridostigmine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000207	0.00186	CcSEcCtD
Pyridostigmine—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000206	0.00185	CcSEcCtD
Pyridostigmine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000205	0.00184	CcSEcCtD
Pyridostigmine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000204	0.00183	CcSEcCtD
Pyridostigmine—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.00181	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000202	0.00181	CcSEcCtD
Pyridostigmine—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000198	0.00178	CcSEcCtD
Pyridostigmine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000198	0.00177	CcSEcCtD
Pyridostigmine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000197	0.00177	CcSEcCtD
Pyridostigmine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000195	0.00175	CcSEcCtD
Pyridostigmine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000192	0.00172	CcSEcCtD
Pyridostigmine—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.00172	CcSEcCtD
Pyridostigmine—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.00171	CcSEcCtD
Pyridostigmine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.00019	0.00171	CcSEcCtD
Pyridostigmine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00019	0.0017	CcSEcCtD
Pyridostigmine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000188	0.00168	CcSEcCtD
Pyridostigmine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000188	0.00168	CcSEcCtD
Pyridostigmine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000186	0.00167	CcSEcCtD
Pyridostigmine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000185	0.00166	CcSEcCtD
Pyridostigmine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000184	0.00165	CcSEcCtD
Pyridostigmine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000184	0.00165	CcSEcCtD
Pyridostigmine—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.00164	CcSEcCtD
Pyridostigmine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000183	0.00164	CcSEcCtD
Pyridostigmine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000182	0.00163	CcSEcCtD
Pyridostigmine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000177	0.00158	CcSEcCtD
Pyridostigmine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.00158	CcSEcCtD
Pyridostigmine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000173	0.00155	CcSEcCtD
Pyridostigmine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000172	0.00154	CcSEcCtD
Pyridostigmine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000172	0.00154	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000171	0.00153	CcSEcCtD
Pyridostigmine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00017	0.00153	CcSEcCtD
Pyridostigmine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.00152	CcSEcCtD
Pyridostigmine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000169	0.00151	CcSEcCtD
Pyridostigmine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000169	0.00151	CcSEcCtD
Pyridostigmine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000168	0.00151	CcSEcCtD
Pyridostigmine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000168	0.0015	CcSEcCtD
Pyridostigmine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000168	0.0015	CcSEcCtD
Pyridostigmine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000166	0.00149	CcSEcCtD
Pyridostigmine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000165	0.00148	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000164	0.00147	CcSEcCtD
Pyridostigmine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000164	0.00147	CcSEcCtD
Pyridostigmine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000164	0.00147	CcSEcCtD
Pyridostigmine—Rash—Vincristine—peripheral nervous system neoplasm	0.000163	0.00146	CcSEcCtD
Pyridostigmine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000163	0.00146	CcSEcCtD
Pyridostigmine—Headache—Vincristine—peripheral nervous system neoplasm	0.000162	0.00145	CcSEcCtD
Pyridostigmine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.00144	CcSEcCtD
Pyridostigmine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000159	0.00143	CcSEcCtD
Pyridostigmine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000156	0.0014	CcSEcCtD
Pyridostigmine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.00139	CcSEcCtD
Pyridostigmine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000154	0.00138	CcSEcCtD
Pyridostigmine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000153	0.00137	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.00136	CcSEcCtD
Pyridostigmine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00015	0.00134	CcSEcCtD
Pyridostigmine—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000146	0.00131	CcSEcCtD
Pyridostigmine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000145	0.0013	CcSEcCtD
Pyridostigmine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000144	0.00129	CcSEcCtD
Pyridostigmine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000144	0.00129	CcSEcCtD
Pyridostigmine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000143	0.00128	CcSEcCtD
Pyridostigmine—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000142	0.00127	CcSEcCtD
Pyridostigmine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000138	0.00124	CcSEcCtD
Pyridostigmine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000136	0.00121	CcSEcCtD
Pyridostigmine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.00121	CcSEcCtD
Pyridostigmine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000133	0.00119	CcSEcCtD
Pyridostigmine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000132	0.00118	CcSEcCtD
Pyridostigmine—Rash—Etoposide—peripheral nervous system neoplasm	0.000132	0.00118	CcSEcCtD
Pyridostigmine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000132	0.00118	CcSEcCtD
Pyridostigmine—Headache—Etoposide—peripheral nervous system neoplasm	0.000131	0.00117	CcSEcCtD
Pyridostigmine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.00117	CcSEcCtD
Pyridostigmine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000129	0.00116	CcSEcCtD
Pyridostigmine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.00114	CcSEcCtD
Pyridostigmine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000126	0.00113	CcSEcCtD
Pyridostigmine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000124	0.00111	CcSEcCtD
Pyridostigmine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000124	0.00111	CcSEcCtD
Pyridostigmine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000122	0.0011	CcSEcCtD
Pyridostigmine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.00109	CcSEcCtD
Pyridostigmine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.00107	CcSEcCtD
Pyridostigmine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000118	0.00106	CcSEcCtD
Pyridostigmine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.00105	CcSEcCtD
Pyridostigmine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.00103	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000113	0.00101	CcSEcCtD
Pyridostigmine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.00101	CcSEcCtD
Pyridostigmine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000981	CcSEcCtD
Pyridostigmine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000979	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000956	CcSEcCtD
Pyridostigmine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000943	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000939	CcSEcCtD
Pyridostigmine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000933	CcSEcCtD
Pyridostigmine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000908	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	9.88e-05	0.000885	CcSEcCtD
Pyridostigmine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	9.74e-05	0.000872	CcSEcCtD
Pyridostigmine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	9.66e-05	0.000865	CcSEcCtD
Pyridostigmine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	9.64e-05	0.000864	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	9.59e-05	0.000858	CcSEcCtD
Pyridostigmine—Urticaria—Epirubicin—peripheral nervous system neoplasm	9.31e-05	0.000834	CcSEcCtD
Pyridostigmine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	9.27e-05	0.00083	CcSEcCtD
Pyridostigmine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	8.94e-05	0.0008	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	8.87e-05	0.000794	CcSEcCtD
Pyridostigmine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	8.64e-05	0.000773	CcSEcCtD
Pyridostigmine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	8.62e-05	0.000772	CcSEcCtD
Pyridostigmine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	8.57e-05	0.000768	CcSEcCtD
Pyridostigmine—Asthenia—Epirubicin—peripheral nervous system neoplasm	8.41e-05	0.000753	CcSEcCtD
Pyridostigmine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	8.02e-05	0.000718	CcSEcCtD
Pyridostigmine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	7.99e-05	0.000716	CcSEcCtD
Pyridostigmine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	7.78e-05	0.000697	CcSEcCtD
Pyridostigmine—Vomiting—Epirubicin—peripheral nervous system neoplasm	7.45e-05	0.000668	CcSEcCtD
Pyridostigmine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	7.42e-05	0.000665	CcSEcCtD
Pyridostigmine—Rash—Epirubicin—peripheral nervous system neoplasm	7.39e-05	0.000662	CcSEcCtD
Pyridostigmine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	7.38e-05	0.000661	CcSEcCtD
Pyridostigmine—Headache—Epirubicin—peripheral nervous system neoplasm	7.34e-05	0.000658	CcSEcCtD
Pyridostigmine—Nausea—Epirubicin—peripheral nervous system neoplasm	6.96e-05	0.000624	CcSEcCtD
Pyridostigmine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	6.9e-05	0.000618	CcSEcCtD
Pyridostigmine—Rash—Doxorubicin—peripheral nervous system neoplasm	6.84e-05	0.000612	CcSEcCtD
Pyridostigmine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	6.83e-05	0.000612	CcSEcCtD
Pyridostigmine—Headache—Doxorubicin—peripheral nervous system neoplasm	6.79e-05	0.000609	CcSEcCtD
Pyridostigmine—Nausea—Doxorubicin—peripheral nervous system neoplasm	6.44e-05	0.000577	CcSEcCtD
